Eledon Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: ELDN
Share price (3/24/26): $2.89
Market cap (3/24/26): $219 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 215 pages Index of Defined Terms

from 10-K 117 pages Amended and Restated Share Purchase Agreement by and Among Tokai Pharmaceuticals, Inc., Otic Pharma, Ltd. and Shareholders of Otic Pharma, Ltd. Dated as of March 2, 2017 Effective as of December 21, 2016

from DEFA14A 115 pages Share Purchase Agreement by and Among Tokai Pharmaceuticals, Inc., Otic Pharma, Ltd. and Shareholders of Otic Pharma, Ltd. Dated as of December 21, 2016

from 8-K 115 pages Share Purchase Agreement by and Among Tokai Pharmaceuticals, Inc., Otic Pharma, Ltd. and Shareholders of Otic Pharma, Ltd. Dated as of December 21, 2016